Prenatal and Postnatal Cardiac Development in Offspring of Hypertensive Pregnancies

Christina Y L Aye1,2, Adam J Lewandowski1, Pablo Lamata3

  • 1Division of Cardiovascular Medicine Oxford Cardiovascular Clinical Research Facility Oxford United Kingdom.

Insights

Infants born to mothers with hypertensive pregnancies show altered cardiac development, particularly in the right ventricle, with changes correlating to disorder severity. These cardiac differences persist postnatally, requiring further long-term study.

Area of Science:

  • Cardiology
  • Neonatology
  • Obstetrics

Background:

  • Pregnancy complications like preterm birth and fetal growth restriction are linked to abnormal prenatal and postnatal cardiac development.
  • This study specifically investigates cardiac development changes in infants exposed to pregnancy hypertension.

Purpose of the Study:

  • To determine if pregnancy hypertension leads to specific alterations in fetal and infant cardiac development.
  • To assess cardiac structure and function in term-born infants exposed to hypertensive pregnancies compared to normotensive pregnancies.

Main Methods:

  • Echocardiography was used to assess left and right ventricular volumes, mass, and function in 134 term-born infants at birth and 3 months of age.
  • Infants were categorized based on maternal pregnancy history: normotensive (n=54) versus preeclampsia or pregnancy-induced hypertension (n=80).
  • Analysis considered the severity of the hypertensive disorder, infant sex, body size, and blood pressure.

Main Results:

  • At birth, ventricular mass indexed to body surface area (LVMI and RVMI) was similar between groups.
  • However, infants from hypertensive pregnancies had significantly smaller right ventricular end-diastolic volume index at birth and 3 months.
  • By 3 months, these infants also showed significantly greater LVMI and RVMI, with right ventricular changes correlating with hypertensive disorder severity.

Conclusions:

  • Infants born to mothers with hypertensive pregnancies exhibit prenatal and postnatal cardiac development differences, particularly in the right ventricle.
  • The observed right ventricular changes are proportional to the severity of the maternal hypertensive disorder.
  • Long-term persistence of these cardiac differences and their association with increased cardiovascular risk warrant further investigation.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
585
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
278
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
365
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
618